ESC Congress 2026 Abstract
Cardiovascular risk factor control after implementation of mandatory risk assessment in a tertiary cardiovascular centre
Cross-sectional study of 5,982 peopleInterventions
Papers on LDL-C target achievement
17 papers8 new in 30 days
Monday, October 26
ESC Congress 2026 Abstract
Lipid-lowering therapy use and LDL-C goal achievement in patients with hypercholesterolaemia or mixed dyslipidaemia in Hong Kong: findings from a retrospective database study
Cross-sectional study of 814,451 peopleHypercholesterolemia
ESC Congress 2026 Abstract
Achievement of LDL-C targets in clinical practice in Spain: a comparison between Observatory II and Observatory I
Cross-sectional study of 4,010 peoplePopulations
ESC Congress 2026 Abstract
Direct measurement vs. Friedewald, Martin-Hopkins and Sampson-NIH equations for LDL-C estimation in Polish primary care population
Cross-sectional study of 13,585 peopleBiomarkers
ESC Congress 2026 Abstract
LDL-C target achievement does not equal risk resolution after ACS: residual atherogenic and inflammatory burden despite maximal oral triple lipid therapy
Cohort study of 426 peopleInterventions
ESC Congress 2026 Abstract
Sustained combination lipid-lowering therapy determines durability of LDL-C <55 mg/dL after ACS: a structured implementation study (2022–2026)
Cohort study in peopleInterventions
ESC Congress 2026 Abstract
Impact of a personalized, fire-to-target lipid-lowering strategy in patients with acute coronary syndrome
Cohort study of 710 peopleAcute coronary syndrome
Nutrition, Metabolism, and Cardiovascular Diseases
Extreme cardiovascular risk as a major barrier to LDL-C target achievement: insights from ITACARE-P registry
Cross-sectional study of 1,904 peopleAtherosclerotic cardiovascular disease
Tuesday, September 15
Journal of Geriatric Cardiology
Sex disparities in LDL-C target achievement among older adults receiving statin therapy
Cross-sectional study of 360 peoplePopulations
Tuesday, September 1
Journal of Lipid Research
Fecal metabolomic profiles by LDL-C target achievement status in statin-treated patients: a cross-sectional study
Cross-sectional study of 124 peopleAmino acid metabolism
Wednesday, August 19
Thursday, August 6
Revista Portuguesa de Cardiologia
Dyslipidemia in primary care patients - Treatment and control (LANTERN study) Algarve
Cross-sectional study of 2,904 peopleDyslipidemia
Monday, November 3
AHA Scientific Sessions 2025 Abstract
The Role of Early Ezetimibe Combination with Atorvastatin in Patients with Atherosclerotic Cardiovascular Disease
Randomized trial in 137 peopleEzetimibe
Thursday, May 15
Cardiology Research
Lipid-Lowering Therapy in Post-Acute Coronary Syndrome Patients: An Observational Study
Cohort study of 122 peopleLipid-lowering therapy
Friday, July 26
Lipids in Health and Disease
Real-world evidence evaluation of LDL-C in hospitalized patients: a population-based observational study in the timeframe 2021-2022
Cohort study of 13,834 peoplePopulations
Friday, July 5
Frontiers in Pharmacology
Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region
Cohort study of 910 peoplePopulations
Thursday, July 28
Geriatrics
Sex Difference in Control of Low-Density Lipoprotein Cholesterol in Older Patients after Acute Coronary Syndrome
Cohort study of 232 peopleAcute coronary syndrome